| General Information of Drug Metabolite (DM) (ID: DM002834) |
| DM Name |
Labetalol N-glucuronide metabolite
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A1 (UGT1A1)
|
DME0004
|
| Conjugation - O-Glucuronidation |
Labetalol
|
[1] , [2] |
|
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME0042
|
| Conjugation - O-Glucuronidation |
Labetalol
|
[1] , [2] |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Conjugation - O-Glucuronidation |
Labetalol
|
[1] , [2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Labetalol |
DR0909
|
Approved |
Essential hypertension |
|
|
| References |
| 1 |
Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica. 2008 Jan;38(1):62-75.
|
| 2 |
Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes Front Pharmacol. 2021 Apr 15;12:655320. doi: 10.3389/fphar.2021.655320.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
